Introduction
Two 15-year-old female monozygotic twins affected by alopecia areata (AA) and thyroiditis presented to our clinical attention. Their family history was negative for thyroiditis.
AA was localized on their occipital and parietal regions, forming an ophiasis pattern.
Case Presentation
Dermatological examination of the first twin (GC, twin A, thyroglobulin antibodies 44.51 IU/mL, thyroperoxidase antibodies >1,000.00 IU/mL); furthermore, twin A also had above-average blood test results: total antioxidant status 494 IU/mL, hemoglobin 11.6 g/dL, transferrin 398 mg/mL, and ferritin 6.67 ng/mL; twin B also had elevated total antioxidant status (407 IU/mL) and vitamin D (10 ng/mL) levels. The remaining tests were negative for both patients.
Treatment with oral betamethasone 2 mg/day was started for both twins for 1 month when they were 14 years old. It was then reduced to 2 mg twice a week in association with vasodilatory and antiseptic lotions of the scalp for 2 months.
This therapy led to a partial remission of dermatological manifestations in both patients. An endocrinological consultation was also recommended to better evaluate thyroid malfunctioning. In patients affected by autoimmune thyroid diseases, the functions of the different skin cell types may be affected not only by variation in thyroid hormone levels but also by the presence of thyroid-specific autoantibodies [3] . Thyroid hormones act on epidermal differentiation and their effects are particularly important for the function of sebaceous, eccrine, and apocrine glands; growth of hair follicles; and synthesis of proteo-and glycosaminoglycans by dermal fibroblasts [4] .
Alopecia Areata in Twins With
Thyroid hormones were found to induce differentiation and apoptosis and inhibit clonal growth of hair follicle epithelial stem cells [5] . Moreover, the immunoregulatory genes that 
